Topic: Metabolex Inc.
J&J licenses late-stage Type 2 diabetes drug from Diamyd; gets preclincal drugs from MetabolexA unit of Johnson & Johnson has partnered with a Nordic pharmaceutical to develop a potential treatment for Type 1 diabetes, the company said Monday. Sweeden's Diamyd Medical AB ...
